Unknown

Dataset Information

0

Kappa chain maturation helps drive rapid development of an infant HIV-1 broadly neutralizing antibody lineage.

ABSTRACT: HIV-infected infants develop broadly neutralizing plasma responses with more rapid kinetics than adults, suggesting the ontogeny of infant responses could better inform a path to achievable vaccine targets. Here we reconstruct the developmental lineage of BF520.1, an infant-derived HIV-specific broadly neutralizing antibody (bnAb), using computational methods developed specifically for this purpose. We find that the BF520.1 inferred naive precursor binds HIV Env. We also show that heterologous cross-clade neutralizing activity evolved in the infant within six months of infection and that, ultimately, only 2% SHM is needed to achieve the full breadth of the mature antibody. Mutagenesis and structural analyses reveal that, for this infant bnAb, substitutions in the kappa chain were critical for activity, particularly in CDRL1. Overall, the developmental pathway of this infant antibody includes features distinct from adult antibodies, including several that may be amenable to better vaccine responses.

SUBMITTER: Simonich CA 

PROVIDER: S-EPMC6522554 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

HIV-infected infants develop broadly neutralizing plasma responses with more rapid kinetics than adults, suggesting the ontogeny of infant responses could better inform a path to achievable vaccine targets. Here we reconstruct the developmental lineage of BF520.1, an infant-derived HIV-specific broadly neutralizing antibody (bnAb), using computational methods developed specifically for this purpose. We find that the BF520.1 inferred naive precursor binds HIV Env. We also show that heterologous c  ...[more]

Similar Datasets

Unknown Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage.
| S-EPMC4368477 | biostudies-literature
Unknown Phenotypic deficits in the HIV-1 envelope are associated with the maturation of a V2-directed broadly neutralizing antibody lineage.
| S-EPMC5806907 | biostudies-other
Unknown The Effects of Framework Mutations at the Variable Domain Interface on Antibody Affinity Maturation in an HIV-1 Broadly Neutralizing Antibody Lineage.
| S-EPMC7379371 | biostudies-literature
Unknown HIV Envelope Glycoform Heterogeneity and Localized Diversity Govern the Initiation and Maturation of a V2 Apex Broadly Neutralizing Antibody Lineage.
| S-EPMC5736302 | biostudies-literature
Unknown Sequencing HIV-neutralizing antibody exons and introns reveals detailed aspects of lineage maturation.
| S-EPMC6175870 | biostudies-other
Unknown Viral variants that initiate and drive maturation of V1V2-directed HIV-1 broadly neutralizing antibodies.
| S-EPMC4637988 | biostudies-literature
Unknown Rapid and Focused Maturation of a VRC01-Class HIV Broadly Neutralizing Antibody Lineage Involves Both Binding and Accommodation of the N276-Glycan.
| S-EPMC6642152 | biostudies-literature
Unknown Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains.
| S-EPMC4104889 | biostudies-literature
Unknown Glycans Function as Anchors for Antibodies and Help Drive HIV Broadly Neutralizing Antibody Development.
| S-EPMC5613947 | biostudies-literature
Unknown HIV broadly neutralizing antibody targets.
| S-EPMC4437463 | biostudies-literature